Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
about
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or BHuman von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia ALessons Learned from Animal Models of Inherited Bleeding Disorders.Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IXLong-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice.Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic miceSurvey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report.Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case reportPrompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Overcoming preexisting humoral immunity to AAV using capsid decoysStratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokineticsLupus anticoagulants associated inhibitor against factor IX in a young patient with haemophilia B.Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis.Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein.The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A
P2860
Q24195006-F6BD7B43-39B3-4C39-926E-4246871748AFQ26738507-09D35849-2F8F-434A-BA3D-C1FAFE477322Q30409863-D9D8D31B-9868-40B5-A7BC-1B2922A1A107Q33608230-83A8B965-C762-4317-8D01-0568BEFEB2B9Q33748093-378EC38F-44BF-4132-BBD7-A3BE9B480197Q36640081-0C5F4EC5-88F6-491F-AC0F-9F03F39EF5F1Q37185097-AF9CB6CE-A88A-4F81-8AEC-5FDD16B97FE6Q37609087-EB6741E8-04E9-408D-8144-F987F3BF1A6AQ37690441-6C508303-0D6E-438B-ADDF-9E2DC3859242Q39084223-56BF8D15-A824-45AB-91A0-DFF741D17109Q39512337-B66191E9-28B2-4F67-807E-962CC118038EQ40173979-B31884F2-4D14-44F9-9A78-DF66B987F92DQ41389490-10124CD4-06D6-47B0-8FC7-97DD7133D056Q41592459-5C4440A0-AF97-480E-BFF7-256063DB42D5Q42056009-5F3661C2-EB92-48EA-A7EA-08C16792657CQ42506636-A3EDA8B3-0BE9-4B4F-8F9F-593D3B9B005DQ45855709-E504D0BF-FECB-4C9C-9769-C17D6220436EQ45869111-C66388FF-6B9A-4448-B667-1333C275DAE8Q45882083-058B7C8C-2EED-44CC-97F7-D5F62753BE84Q57816367-D3001FA3-BDD3-4027-BAEC-A5BBC6D4B24D
P2860
Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune tolerance induction in ...... dations for clinical practice.
@en
Immune tolerance induction in ...... dations for clinical practice.
@nl
type
label
Immune tolerance induction in ...... dations for clinical practice.
@en
Immune tolerance induction in ...... dations for clinical practice.
@nl
prefLabel
Immune tolerance induction in ...... dations for clinical practice.
@en
Immune tolerance induction in ...... dations for clinical practice.
@nl
P2093
P2860
P1476
Immune tolerance induction in ...... ndations for clinical practice
@en
P2093
Gary Benson
Günter Auerswald
Ivo Elezović
Massimo Morfini
Rolf Ljung
Silva Zupančić Salek
Thierry Lambert
P2860
P304
P356
10.1111/J.1600-0609.2012.01754.X
P50
P577
2012-02-07T00:00:00Z